Subsequent experimental validation revealed that lncRNA FOXD1-AS1 has the potential to enhance the expression of Osteopontin (OPN), also known as secreted phosphoprotein 1 (SPP1), in pancreatic cancer CSCs among the identified candidate genes. This evidence concerns the gene FOXD1 and pancreatic neoplasm.